MCL1 and plasma cell myeloma: However, expression of Mcl-1, which has been shown to be an important regulator of myeloma cell survival (Gomez-Bougie et al, 2004), was found to be decreased in NCI-H929 cells treated with 1 μM PBOX-15, with expression completely abolished after 48 h (Figure 5D).